Global Hormone Replacement Therapy Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 105

Report ID: 4143

Hormone replacement therapy refers to the treatment of the patients with growth hormone deficiency due to conditions such as dwarfism or women nearing menopause, which requires replacement of hormones in the body whose levels have become low.
Hormonal imbalance disorders, with an increase in the geriatric population, is one of the major factors responsible for the growth of this market. The risk of cancer associated with the HRT certainly restricts the growth of this market. The combination HRT increases the risk of breast cancer by nearly 70%, even when used for a short period of time. The Cancer Research UK has shown in past that HRT increases the risk for several types of cancers, including uterus and ovarian cancers. The United States is expected to have the largest market share in the forecast period. Growing geriatric population is one of the primary factors for the growth of the market.
In 2018, the global Hormone Replacement Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Hormone Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Hormone Replacement Therapy development in United States, Europe and China.

The key players covered in this study
F. Hoffmann-La Roche
Novartis
Novo Nordisk
Amgen
ANI Pharmaceuticals
Bayer
Eli Lilly
Hisamitsu Pharmaceutical
Ipsen
Merck
Mylan Laboratories
Orion
QuatRx Pharmaceuticals
Teva Pharmaceutical Industries
TherapeuticsMD

Market segment by Type, the product can be split into
Estrogen Replacement Therapy
Growth Hormone Replacement Therapy

Market segment by Application, split into
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Hormone Replacement Therapy status, future forecast, growth opportunity, key market and key players.
To present the Hormone Replacement Therapy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Hormone Replacement Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Hormone Replacement Therapy Market Size Growth Rate by Type (2014-2025)
1.4.2 Estrogen Replacement Therapy
1.4.3 Growth Hormone Replacement Therapy
1.5 Market by Application
1.5.1 Global Hormone Replacement Therapy Market Share by Application (2014-2025)
1.5.2 Menopause
1.5.3 Hypothyroidism
1.5.4 Male Hypogonadism
1.5.5 Growth Hormone Deficiency
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Hormone Replacement Therapy Market Size
2.2 Hormone Replacement Therapy Growth Trends by Regions
2.2.1 Hormone Replacement Therapy Market Size by Regions (2014-2025)
2.2.2 Hormone Replacement Therapy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Hormone Replacement Therapy Market Size by Manufacturers
3.1.1 Global Hormone Replacement Therapy Revenue by Manufacturers (2014-2019)
3.1.2 Global Hormone Replacement Therapy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Hormone Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.2 Hormone Replacement Therapy Key Players Head office and Area Served
3.3 Key Players Hormone Replacement Therapy Product/Solution/Service
3.4 Date of Enter into Hormone Replacement Therapy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Hormone Replacement Therapy Market Size by Type (2014-2019)
4.2 Global Hormone Replacement Therapy Market Size by Application (2014-2019)

5 United States
5.1 United States Hormone Replacement Therapy Market Size (2014-2019)
5.2 Hormone Replacement Therapy Key Players in United States
5.3 United States Hormone Replacement Therapy Market Size by Type
5.4 United States Hormone Replacement Therapy Market Size by Application

6 Europe
6.1 Europe Hormone Replacement Therapy Market Size (2014-2019)
6.2 Hormone Replacement Therapy Key Players in Europe
6.3 Europe Hormone Replacement Therapy Market Size by Type
6.4 Europe Hormone Replacement Therapy Market Size by Application

7 China
7.1 China Hormone Replacement Therapy Market Size (2014-2019)
7.2 Hormone Replacement Therapy Key Players in China
7.3 China Hormone Replacement Therapy Market Size by Type
7.4 China Hormone Replacement Therapy Market Size by Application

8 Japan
8.1 Japan Hormone Replacement Therapy Market Size (2014-2019)
8.2 Hormone Replacement Therapy Key Players in Japan
8.3 Japan Hormone Replacement Therapy Market Size by Type
8.4 Japan Hormone Replacement Therapy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Hormone Replacement Therapy Market Size (2014-2019)
9.2 Hormone Replacement Therapy Key Players in Southeast Asia
9.3 Southeast Asia Hormone Replacement Therapy Market Size by Type
9.4 Southeast Asia Hormone Replacement Therapy Market Size by Application

10 India
10.1 India Hormone Replacement Therapy Market Size (2014-2019)
10.2 Hormone Replacement Therapy Key Players in India
10.3 India Hormone Replacement Therapy Market Size by Type
10.4 India Hormone Replacement Therapy Market Size by Application

11 Central & South America
11.1 Central & South America Hormone Replacement Therapy Market Size (2014-2019)
11.2 Hormone Replacement Therapy Key Players in Central & South America
11.3 Central & South America Hormone Replacement Therapy Market Size by Type
11.4 Central & South America Hormone Replacement Therapy Market Size by Application

12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Hormone Replacement Therapy Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Hormone Replacement Therapy Business (2014-2019)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Hormone Replacement Therapy Introduction
12.2.4 Novartis Revenue in Hormone Replacement Therapy Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Novo Nordisk
12.3.1 Novo Nordisk Company Details
12.3.2 Company Description and Business Overview
12.3.3 Hormone Replacement Therapy Introduction
12.3.4 Novo Nordisk Revenue in Hormone Replacement Therapy Business (2014-2019)
12.3.5 Novo Nordisk Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Hormone Replacement Therapy Introduction
12.4.4 Amgen Revenue in Hormone Replacement Therapy Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 ANI Pharmaceuticals
12.5.1 ANI Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Hormone Replacement Therapy Introduction
12.5.4 ANI Pharmaceuticals Revenue in Hormone Replacement Therapy Business (2014-2019)
12.5.5 ANI Pharmaceuticals Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Hormone Replacement Therapy Introduction
12.6.4 Bayer Revenue in Hormone Replacement Therapy Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Eli Lilly
12.7.1 Eli Lilly Company Details
12.7.2 Company Description and Business Overview
12.7.3 Hormone Replacement Therapy Introduction
12.7.4 Eli Lilly Revenue in Hormone Replacement Therapy Business (2014-2019)
12.7.5 Eli Lilly Recent Development
12.8 Hisamitsu Pharmaceutical
12.8.1 Hisamitsu Pharmaceutical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Hormone Replacement Therapy Introduction
12.8.4 Hisamitsu Pharmaceutical Revenue in Hormone Replacement Therapy Business (2014-2019)
12.8.5 Hisamitsu Pharmaceutical Recent Development
12.9 Ipsen
12.9.1 Ipsen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Hormone Replacement Therapy Introduction
12.9.4 Ipsen Revenue in Hormone Replacement Therapy Business (2014-2019)
12.9.5 Ipsen Recent Development
12.10 Merck
12.10.1 Merck Company Details
12.10.2 Company Description and Business Overview
12.10.3 Hormone Replacement Therapy Introduction
12.10.4 Merck Revenue in Hormone Replacement Therapy Business (2014-2019)
12.10.5 Merck Recent Development
12.11 Mylan Laboratories
12.12 Orion
12.13 QuatRx Pharmaceuticals
12.14 Teva Pharmaceutical Industries
12.15 TherapeuticsMD

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details